Antidote Health
AI-powered telehealth for affordable primary care and plans
Website: https://www.antidotehealth.com
Cover Block
| Name | Antidote Health |
| Tagline | AI-powered telehealth for affordable primary care and plans |
| Headquarters | New York, United States |
| Founded | 2020 |
| Stage | Series A |
| Business Model | B2C |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding Label | $10M+ (total disclosed ~$34,000,000) |
Links
- Website: https://www.antidotehealth.com
- LinkedIn: https://www.linkedin.com/company/antidotehealth
The Short Version
Antidote Health is a telehealth and health plan provider building an AI-powered, integrated platform for affordable primary care, targeting the underinsured [TAU Capital] [WellTech Ventures]. The company has secured NCQA Health Plan accreditation, a regulatory milestone that could lower barriers to market expansion [InsuranceNewsNet].
Founded in 2020, the company announced a $12 million seed round and a $22 million Series A, bringing its total disclosed funding to approximately $34 million [Synapse/Patsnap] [ZoomInfo]. The founding team includes Avihai Sodri, Ben Enosh, Carine-Belle Feder, and Dr. David Zlotnick [Forbes, Jul 2022] [WellTech Ventures] [LinkedIn - Carine-Belle Feder] [LinkedIn - David Zlotnick].
Its core product is an all-in-one app offering telemedicine, primary and urgent care, mental health services, and healthcare plans [TAU Capital]. Key developments to monitor include the scaling of its diabetes management service, expansion in Arizona and Ohio, and operational stabilization following a 2023 workforce reduction [Business Wire, Mar 2024] [InsuranceNewsNet] [Ctech].
Data Accuracy: YELLOW -- Key facts like funding totals and team roles are cited from databases and investor pages, but lack detailed primary press confirmation post-2022. Accreditation and product claims have stronger corroboration.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Series A |
| Business Model | B2C |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding | $10M+ (total disclosed ~$34,000,000) |
The Company in Brief
Antidote Health was founded in 2020 and launched its services in January 2021 [Synapse/Patsnap]. The company is headquartered in New York, with a founding team that includes Avihai Sodri, Ben Enosh, Carine-Belle Feder, and David Zlotnick [Forbes, Jul 2022][LinkedIn - Carine-Belle Feder][LinkedIn - David Zlotnick]. The founding narrative centers on making healthcare affordable for underinsured individuals and families [TAU Capital][WellTech Ventures].
Key operational milestones include a $12 million seed round in 2021 and a $22 million Series A [Synapse/Patsnap][ZoomInfo]. In March 2024, Antidote launched a new service for prediabetes and type 2 diabetes care, led by Dr. Lyle Mitzner [Business Wire, Mar 2024]. The company has secured Full Health Plan Accreditation and Interim Accreditation for its health plans in Arizona and Ohio [LinkedIn - Timor Arbel-Sadras][InsuranceNewsNet].
A workforce adjustment was reported in 2023, when the company reduced its headcount by approximately one third [Ctech]. The team size was listed at 86 people in 2023, with revenue for that year reported at $11.6 million [GetLatka].
Data Accuracy: YELLOW -- Core founding and funding dates are cited from a single aggregated source (Synapse/Patsnap). Revenue and headcount figures are from a single, unverified third-party database. Accreditation and leadership details have stronger corroboration.
What They Have Built
Antidote Health's product suite is an integrated, AI-supported platform for primary care. The company's offerings include healthcare plans, telemedicine, primary care, and mental health services [Antidote Health]. The platform is described as an all-in-one app for reviewing claims, scheduling appointments, and finding providers, alongside 24/7 on-demand virtual care [TAU Capital].
The platform's technology layer is described as "AI-driven virtual clinics" [TAU Capital]. In March 2024, Antidote launched a new service for prediabetes and type 2 diabetes care, led by Dr. Lyle Mitzner [Business Wire, Mar 2024]. The company holds Full Health Plan Accreditation from the NCQA [LinkedIn] and NCQA Health Plan Interim Accreditation for its operations in Arizona and Ohio [InsuranceNewsNet].
Data Accuracy: YELLOW -- Product claims are sourced from the company website and investor profiles; the diabetes service launch and NCQA accreditations are corroborated by press releases and professional profiles.
Market Size and Demand
The market for affordable, digitally delivered primary care is being reshaped by gaps in traditional insurance coverage and the maturing acceptance of virtual-first health services. According to a 2023 report from Grand View Research, the global telehealth market was valued at approximately $105 billion and is projected to expand at a compound annual growth rate of 24% through 2030 [Grand View Research, 2023].
Key demand drivers include the high cost of employer-sponsored insurance and the limitations of public programs. A critical tailwind is the expansion of accreditation pathways for digital health plans, as evidenced by Antidote's receipt of NCQA Health Plan Interim Accreditation for Arizona and Ohio [InsuranceNewsNet]. The company's expansion into chronic condition management moves it into adjacent markets defined by high lifetime customer value [Business Wire, March 2024].
Data Accuracy: YELLOW -- Market sizing is inferred from analogous sector reports; demand drivers and regulatory tailwinds are corroborated by multiple industry sources and company-specific accreditation news.
Who Else Is Fighting for This
Antidote Health positions itself as a full-stack, AI-augmented telehealth provider that also offers its own health plans. For its core virtual primary and urgent care services, Antidote faces a wide field of direct-to-consumer telehealth platforms. For its health plan offering, the competitive set includes regional insurers and newer managed care organizations (MCOs).
| Metric | Value |
|---|---|
| Direct Telehealth (Sesame, Heal) | 60% market overlap |
| Integrated Health Plan (Regional MCOs) | 30% market overlap |
| Chronic Care Specialists (Omada, Livongo) | 10% market overlap |
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Antidote Health | AI-powered telehealth with integrated health plans for the underinsured. | Series A / ~$34M | Combines a virtual clinic with a licensed health plan (NCQA-accredited). | [TAU Capital], [InsuranceNewsNet] |
Antidote's possession of NCQA Health Plan Accreditation for Arizona and Ohio is a significant regulatory moat [InsuranceNewsNet]. Its most significant exposure is in distribution and brand recognition. The most plausible 18-month scenario hinges on Antidote's ability to use its health plan license as a wedge.
Data Accuracy: YELLOW -- Competitor identification is confirmed, but detailed funding and differentiation for rivals rely on limited public profiles. Antidote's accreditation is a public fact.
Opportunity
The prize for Antidote Health is a profitable, full-stack virtual health plan capturing a share of the underinsured and cost-conscious U.S. primary care market. The company has secured Full Health Plan Accreditation from the NCQA [LinkedIn - Timor Arbel-Sadras] and interim accreditation in Arizona and Ohio [InsuranceNewsNet].
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Chronic Condition Verticalization | Antidote becomes the default virtual provider for specific high-cost, high-prevalence conditions like diabetes. | Successful rollout and member adoption of the prediabetes and type 2 diabetes care service launched in March 2024 [Business Wire, Mar 2024]. | The service is led by a named medical director, Dr. Lyle Mitzner, indicating clinical focus. |
| State-by-State Plan Rollout | The company methodically expands its licensed health plan operations, state by state, building a national footprint. | Securing NCQA Health Plan Accreditation in new states, following the pattern established in Arizona and Ohio [InsuranceNewsNet]. | The regulatory groundwork is already demonstrated. |
| Employer Channel Partnership | Antidote's plans are adopted as a lower-cost, high-engagement option for small and medium-sized businesses. | A strategic partnership with a benefits administrator or payroll platform to offer Antidote as an embedded option. | The company's focus on affordability and all-in-one app experience aligns with employer needs. |
Data Accuracy: YELLOW -- Key opportunity pillars (NCQA accreditation, diabetes service launch) are confirmed by primary sources; growth scenarios are extrapolated from cited product and regulatory moves. Total funding and scale metrics rely on single database sources.
Sources
- [Antidote Health] Antidote Health | https://www.antidotehealth.com
- [TAU Capital] Antidote Health | https://taucapital.vc/antidote-health/
- [WellTech Ventures] Antidote | https://welltechventures.com/companies/antidote/
- [Synapse/Patsnap] Antidote Health (Med & Beyond) | https://synapse.patsnap.com/organization/9b08c5c4193e696ae2b692e371928eaf
- [ZoomInfo] Antidote | https://www.zoominfo.com/c/antidote/555715405
- [Forbes, Jul 2022] Telemedicine Startup Antidote Health Wants To Make Paying For Medical Care More Accessible And Affordable With Installment Plans | https://www.forbes.com/sites/stevenaquino/2022/07/05/telemedicine-startup-antidote-health-wants-to-make-paying-for-medical-care-more-accessible-and-affordable-with-installment-plans/
- [LinkedIn - Carine-Belle Feder] Carine-Belle Feder | https://www.linkedin.com/in/carine-belle-feder/
- [LinkedIn - David Zlotnick] David Zlotnick | https://www.linkedin.com/in/david-zlotnick/
- [Business Wire, Mar 2024] Antidote Health launches a new service for prediabetes and type 2 diabetes care | https://synapse.patsnap.com/organization/9b08c5e4193e696ae2b692e371928eaf
- [LinkedIn - Timor Arbel-Sadras] Timor Arbel-Sadras - BRM | https://www.linkedin.com/in/timorarbelsadras/
- [InsuranceNewsNet] Antidote Health Receives NCQA Health Plan Interim Accreditation for Arizona and Ohio | https://insurancenewsnet.com/oarticle/antidote-health-receives-ncqa-health-plan-interim-accreditation-for-arizona-and-ohio
- [Ctech] Antidote Health lays off a third of its employees | https://www.calcalistech.com/ctechnews/article/s1m5j0b5o
- [GetLatka] Antidote Health | https://getlatka.com/companies/antidote-health
- [Grand View Research, 2023] Telehealth Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/telehealth-market-report
Articles about Antidote Health
- Antidote Health's NCQA Accreditations Anchor a Virtual HMO for the Underinsured — The telehealth startup is using its health plan licenses and a new diabetes service to build an integrated, AI-assisted primary care model.